This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Familial defective apoprotein B-100

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

In this genetic hyperlipidaemia cholesterol levels are raised (usually cholesterol 7.5-16 mmol/L) and triglyceride levels are below 2.3 mmol/L. LDL-cholesterol is increased.

In this condition a mutation of apo B intereferes with binding of LDL. The most common cause of this condition is due to a substitution of an amino-acid at position 3500. This mutation has an incidence of approximately 1 in 600 in the general population although it generally does not produce an especially severe hyperlipidaemia.

This is an example of a type IIa hyperlipidaemia according to the Who/Fredrickson classification of primary hyperlipidaemias.

Clinical features are similar to those seen in familial hypercholesterolaemia (FH).

It has been estimated that up to 4% of patients with clinical FH may have familial defective apo B.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.